Hangzhou Tigermed Consulting Co., Ltd (HKG: 3347)

Hangzhou Tigermed Consulting Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 21, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019
Market Capitalization	52,626	49,362	98,995	127,899	165,928	52,951
Market Cap Growth	5.43%	-50.14%	-22.60%	-22.92%	213.36%	117.48%
Enterprise Value	58,494	48,853	96,619	121,314	155,071	52,650
Last Close Price	32.35	34.69	87.65	95.49	172.75	-
PE Ratio	-	22.13	43.64	36.25	79.85	56.24
PS Ratio	8.14	6.07	12.36	19.99	43.77	16.89
PB Ratio	2.27	1.83	3.86	5.06	7.82	8.57
P/TBV Ratio	3.09	2.50	5.22	6.47	9.61	15.93
P/FCF Ratio	81.72	53.55	96.34	98.75	165.90	111.47
P/OCF Ratio	52.42	38.95	64.51	73.18	139.90	89.72
EV/Sales Ratio	8.00	6.01	12.06	18.96	40.90	16.79
EV/EBITDA Ratio	32.71	23.64	44.48	67.76	136.22	62.22
EV/EBIT Ratio	40.66	26.23	48.48	73.55	148.61	65.99
EV/FCF Ratio	77.93	53.00	94.03	93.66	155.05	110.83
Debt / Equity Ratio	0.17	0.14	0.12	0.05	0.02	0.18
Debt / EBITDA Ratio	2.49	1.68	1.34	0.64	0.32	1.35
Debt / FCF Ratio	6.13	4.00	2.99	0.92	0.39	2.40
Asset Turnover	0.23	0.26	0.28	0.24	0.24	0.47
Inventory Turnover	172.55	199.06	302.27	544.16	566.25	1740.11
Quick Ratio	1.32	2.72	2.95	4.46	10.17	1.86
Current Ratio	1.37	2.74	2.98	4.50	10.22	1.88
Return on Equity (ROE)	4.19%	9.12%	10.50%	17.64%	17.36%	22.80%
Return on Assets (ROA)	2.77%	3.70%	4.30%	3.88%	4.06%	7.55%
Return on Capital (ROIC)	2.96%	3.97%	4.69%	4.22%	4.44%	8.76%
Earnings Yield	1.73%	4.52%	2.29%	2.76%	1.25%	1.78%
FCF Yield	1.22%	1.87%	1.04%	1.01%	0.60%	0.90%
Dividend Yield	1.57%	1.80%	0.71%	0.64%	0.21%	-
Payout Ratio	65.49%	29.13%	24.52%	9.89%	15.50%	31.60%
Buyback Yield / Dilution	0.44%	0.07%	0.62%	-9.01%	-7.27%	0.63%
Total Shareholder Return	0.44%	1.87%	1.33%	-8.37%	-7.07%	0.63%

Source: S&P Capital IQ. Standard template. Financial Sources.